...
首页> 外文期刊>The Journal of Experomental Medicine >Release of the mucosal mast cell granule chymase, rat mast cell protease-II, during anaphylaxis is associated with the rapid development of paracellular permeability to macromolecules in rat jejunum.
【24h】

Release of the mucosal mast cell granule chymase, rat mast cell protease-II, during anaphylaxis is associated with the rapid development of paracellular permeability to macromolecules in rat jejunum.

机译:过敏反应期间粘膜肥大细胞颗粒糜酶,大鼠肥大细胞蛋白酶II的释放与大鼠空肠对大分子的细胞旁通透性的快速发展有关。

获取原文
           

摘要

The soluble granule chymase, rat mast cell protease-II (RMCP-II), is abundantly expressed in intestinal mucosal mast cells (MMC) but its function is not known. One hypothesis is that RMCP-II degrades the epithelial basement membrane and promotes the loss of enterocytes typically associated with type I hypersensitivity reactions in the rat. To test this hypothesis more directly, ex vivo perfusion of the cranial mesenteric artery and jejunal lumen was used to monitor the anaphylactic release of RMCP-II and its effects on mucosal permeability and epithelial integrity. Within 2 min of intravascular challenge with soluble adult Nippostrongylus brasiliensis worm antigen there was a 1,000-fold (P 0.02) increase in the concentration of RMCP-II in the vascular perfusate from the jejunum of Nippostrongylus-sensitized rats but not the controls. Similarly, translocation of RMCP-II into the gut lumen increased 10-fold (P 0.02) after 2 min only in worm antigen-challenged immune rats. Using an identical protocol, but incorporating Evans blue-labeled human serum albumin (EB-HSA) in the vascular perfusate, the timing of the release of RMCP-II into the two compartments was very similar to the first experiment and furthermore the translocation of EB-HSA increased 18-fold (P 0.05) after 4 min in sensitized rats challenged with worm antigen. To examine the effects of RMCP-II more directly 1 mg of the highly purified chymase was introduced into the cranial mesenteric artery in ex vivo perfused normal rats. A significant (P 0.05) 70-fold increase in concentration of RMCP-II in jejunal perfusate occurred after 6 min. In a repeat dose-response experiment, infusion of 0.375, 0.75, or 1.5 mg of RMCP-II, together with EB-HSA, established that the cumulative amounts of RMCP-II and EB-HSA translocated from the vasculature to the gut lumen in each perfusion (during the 10-min period of RMCP-II infusion) were significantly correlated. Analysis of intestinal perfusates by SDS-PAGE and by Western blotting using monoclonal anti-RMCP-II antibody confirmed that there was a concomitant translocation of both the protease and EB-HSA into the gut lumen. Histological evaluation of the mucosa failed to reveal any significant morphological change in any of the experiments. The rapid development of macromolecular leak, its association with the translocation of RMCP-II, and the absence of gross epithelial lesions, suggest for the first time that a mast cell granule chymase increases epithelial permeability via a paracellular route and implies that the substrate may be a protein, or proteins, in the epithelial junctional complex.
机译:可溶性颗粒糜酶,大鼠肥大细胞蛋白酶II(RMCP-II)在肠粘膜肥大细胞(MMC)中大量表达,但其功能尚不清楚。一种假设是RMCP-II会降解上皮基底膜并促进通常与大鼠I型超敏反应有关的肠上皮细胞的丢失。为了更直接地检验该假设,使用了颅内肠系膜动脉和空肠管腔的离体灌注来监测RMCP-II的过敏性释放及其对粘膜通透性和上皮完整性的影响。在用成年的巴西拟南芥蠕虫抗原进行血管内攻击后2分钟内,对日本拟南芥致敏大鼠的空肠(而非对照)的空肠中的血管灌注液中RMCP-II的浓度增加了1000倍(P <0.02)。同样,仅在蠕虫抗原攻击的免疫大鼠中,RMCP-II进入肠腔的转运在2分钟后增加了10倍(P <0.02)。使用相同的方案,但在血管灌注液中掺入了埃文斯蓝标的人血清白蛋白(EB-HSA),RMCP-II释放到两个腔室中的时间与第一个实验非常相似,而且EB易位在感染了蠕虫抗原的致敏大鼠中,-HSA在4分钟后增加了18倍(P <0.05)。为了更直接地检查RMCP-II的作用,在离体灌注正常大鼠中将1 mg高度纯化的糜酶引入颅系膜动脉。 6分钟后,空肠灌流液中RMCP-II的浓度显着增加(P <0.05)70倍。在重复的剂量反应实验中,将0.375、0.75或1.5 mg的RMCP-II与EB-HSA一起输注可确定RMCP-II和EB-HSA的累积量从血管系统转移至肠腔。每次灌注(在RMCP-II灌注的10分钟期间)均显着相关。通过SDS-PAGE和使用单克隆抗RMCP-II抗体的Western印迹分析肠灌注液,证实了蛋白酶和EB-HSA都同时转移到肠腔中。粘膜的组织学评估未能在任​​何实验中揭示任何明显的形态变化。大分子渗漏的迅速发展,与RMCP-II的易位相关以及不存在明显的上皮病变,首次提示肥大细胞颗粒糜酶通过旁细胞途径增加上皮通透性,并暗示底物可能是上皮连接复合物中的一种或多种蛋白质。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号